Primus In News
Indian CDMOs get a growth pill
28-01-2026
Nilaya Varma, Group CEO and Co-Founder, Primus Partners, shared his view that the free trade agreement would open access to Europe’s pharmaceutical and medical devices market, valued at around $572 billion, while strengthening India’s position as a global manufacturing hub.
Explore Related Insights
- PhysicsWallah share listing tomorrow: Analysts suggest long-term hold with partial profit booking; check GMP
- Punjab: Workshop organized to exchange ideas for family-based welfare delivery system
- Fragmented fintech industry dither over effectiveness of self regulation
- FMCG, dairy and agri leaders welcome budget 2026 as catalyst for rural incomes & consumption
